Profil
Peter Ordentlich is the founder of Syndax Pharmaceuticals, Inc. since 2005, serving as Chief Scientific Officer.
Former positions include Principal at The Salk Institute for Biological Studies and Research Scientist at X-Ceptor Therapeutics, Inc. Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
Postes actifs de Peter Ordentlich
| Sociétés | Poste | Début |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Fondateur | 11/10/2005 |
Anciens postes connus de Peter Ordentlich
| Sociétés | Poste | Fin |
|---|---|---|
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Corporate Officer/Principal | - |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Peter Ordentlich
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Commercial Services |
















